Deep experience to guide your innovation
Xontogeny’s team has experience across scientific diligence, drug and medical technology development and operations from preclinical stages through commercialization. Through the efforts of the team, Xontogeny supports and stays connected with its entrepreneurs and larger community of collaborators by providing strategic and investment leadership to create successful outcomes across its portfolio of companies.
Chris Garabedian founded Xontogeny in June of 2016 to support multiple promising technologies from early development through clinical proof of concept.
Joe Edelman founded the hedge fund Perceptive Advisors, LLC in 1999, to further the progress of promising companies within the life sciences industry.
Adam Stone joined Perceptive Advisors, a hedge fund focused on supporting the progress of the life sciences industry, in 2006.